Relief Therapeutics SA 

$0.2230
83
-$0.04-15.85% Monday 20:00

Statistics

Day High
0.241
Day Low
0.241
52W High
4.88
52W Low
0.161
Volume
50
Avg. Volume
4,353
Mkt Cap
0
P/E Ratio
-
Dividend Yield
-
Dividend
-

Earnings

30JunExpected
Q3 2019
Q4 2019
Q1 2020
Q2 2020
Q3 2020
Q4 2020
Q1 2021
-0
-0
0
0
Expected EPS
0
Actual EPS
-0.0024

People Also Follow

This list is based on the watchlists of people on Stock Events who follow RLFTF. It's not an investment recommendation.

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.
Gilead Sciences
GILD
Mkt Cap180.64B
Gilead Sciences is a biopharmaceutical company that competes in developing treatments for viral diseases, a similar area of focus as Relief Therapeutics.
Regeneron Pharmaceuticals
REGN
Mkt Cap81.77B
Regeneron Pharmaceuticals is involved in developing medications for serious medical conditions, directly competing with Relief Therapeutics in the biopharmaceutical space.
Moderna
MRNA
Mkt Cap55.09B
Moderna is known for its mRNA technology used in vaccines and therapies, competing with Relief Therapeutics in the innovative treatment sector.
Pfizer
PFE
Mkt Cap159.36B
Pfizer develops and manufactures drugs and vaccines, including treatments for COVID-19, making it a competitor in the pandemic response market.
Astrazeneca
AZN
Mkt Cap252.33B
AstraZeneca is a global biopharmaceutical company working on vaccines and treatments for various diseases, including COVID-19, competing with Relief Therapeutics.
BioNTech
BNTX
Mkt Cap25.64B
BioNTech SE, in partnership with Pfizer, developed a COVID-19 vaccine, directly competing with Relief Therapeutics' efforts in pandemic-related treatments.
Johnson & Johnson
JNJ
Mkt Cap645.95B
Johnson & Johnson, through its pharmaceutical division, develops treatments and vaccines, including for COVID-19, competing in the same space as Relief Therapeutics.
Novavax
NVAX
Mkt Cap1.53B
Novavax is focused on developing vaccines, including for COVID-19, making it a direct competitor in the vaccine development space.
Sorrento Therapeutics
SRNE
Mkt Cap385,896
Sorrento Therapeutics works on therapies for COVID-19, cancer, and pain, competing with Relief Therapeutics in multiple therapeutic areas.

About

MindMaze Therapeutics Holding SA operates as a commercial-stage biopharmaceutical and neurotechnology company in Asia, the United States, Switzerland, rest of Europe, and internationally. The company offers MindPod system, a supervised in-clinic neurorehabilitation system designed to initiate and intensify the recovery journey; MindMotion GO, which extends protocolized neurotherapeutics into outpatient and home settings; MindMotion Companion, an application that manages prescription, monitoring and documentation across MindMaze Therapeutics' neurotherapeutics ecosystem; and the patient app, a patient-facing mobile application, that supports clinic-to-home continuity by making prescribed therapy easy to follow outside the clinic. It also provides Izar hand therapy device which supports fine motor rehabilitation; Physilog sensor, a wearable inertial sensing device designed to quantify human movement; toaprun, a training for Parkinson's therapy-reimagined through play. The company was founded in 2012 and is headquartered in Geneva, Switzerland.
Show more...
CEO
Zach Henderson
Employees
10
Country
Switzerland
ISIN
CH0100191136
WKN
000A3EFB5

Listings

0 Comments

Share your thoughts

FAQ

What is Relief Therapeutics SA stock price today?
The current price of RLFTF is $0.22 USD — it has decreased by -15.85% in the past 24 hours. Watch Relief Therapeutics SA stock price performance more closely on the chart.
What is Relief Therapeutics SA stock ticker?
Depending on the exchange, the stock ticker may vary. For instance, on OTCM exchange Relief Therapeutics SA stocks are traded under the ticker RLFTF.
Is Relief Therapeutics SA stock price growing?
RLFTF stock has risen by +0% compared to the previous week, the month change is a -23.71% fall, over the last year Relief Therapeutics SA has showed a -93.6% decrease.
What were Relief Therapeutics SA earnings last quarter?
RLFTF earnings for the last quarter are -0 USD per share, whereas the estimation was 0 USD resulting in a -∞% surprise. The estimated earnings for the next quarter are N/A USD per share.
How many employees does Relief Therapeutics SA have?
As of September 05, 2026, the company has 10 employees.
In which sector is Relief Therapeutics SA located?
Relief Therapeutics SA operates in the Health & Wellness sector.
When did Relief Therapeutics SA complete a stock split?
The last stock split for Relief Therapeutics SA was on May 05, 2023 with a ratio of 1:400.
Where is Relief Therapeutics SA headquartered?
Relief Therapeutics SA is headquartered in Geneva, Switzerland.